Measurement issues in quality-of-life assessments

Oncology Nursing Forum

Volumn 33, Issue SUPPL. 1, 2006, Pages 13-21

  Varricchio, Claudette G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; METHODOLOGY; NEOPLASM; NURSING; NURSING ASSESSMENT; ONCOLOGY NURSING; PATIENT SELECTION; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; REVIEW; SICKNESS IMPACT PROFILE; STATISTICAL ANALYSIS;

DATA INTERPRETATION, STATISTICAL; HUMANS; NEOPLASMS; NURSING ASSESSMENT; ONCOLOGIC NURSING; PATIENT SELECTION; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SICKNESS IMPACT PROFILE;

EID: 34249095695     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/06.ONF.S1.13-21     Document Type: Article

References (60)

1. Aaronson, N.K., Admedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N.J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365-376. (Pubitemid 23073154)
2. Berger, A.M., Berry, D.L., Christopher, K.A., Greene, A.L., Maliski, S., Swenson, K.K., et al. (2005). Oncology Nursing Society year 2004 research priorities survey. Oncology Nursing Forum, 32, 281-290.
3. Berry, J. (1980). Acculturation as varieties of adaptation. In A.M. Padilla (Ed.), Acculturation: Theory, models, and some new findings (pp. 9-25). Boulder, CO: Westview Press.
4. Brislin, R.W. (1970). Back-translation for cross-cultural research. Journal of Cross-Cultural Psychology, 1, 185-216.
5. Brislin, R.W. (1986). The wording and translation of research instruments. In W.J. Lonner & J.W. Berry (Eds.), Field methods in cross-cultural research (pp. 137-164). Beverly Hills, CA: Sage.
6. Cella, D., Bullinger, M., Scott, C., Barofsky, I., & Clinical Significance Consensus Meeting Group. (2002). Group vs individual approaches to understanding clinical significance of differences or changes in quality of life. Mayo Clinic Proceedings, 77, 384-392. (Pubitemid 34260747)
7. Cella, D.F., & Cherin, E.A. (1988). Quality of life during and after cancer treatment. Comprehensive Therapy, 14(5), 69-75.
8. Cella, D.F., Tulsky, D.S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., et al. (1993). The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. Journal of Clinical Oncology, 11, 570-579. (Pubitemid 23071057)
9. Chauhan, C., Eppard, W., & Perroti, J. (2004). The patient advocate perspective on assessing the clinical significance for quality-of-life measures. Journal of Cancer Integrative Medicine, 2, 155-157.
10. Dijkers, M.P. (2003). Individualization in quality of life measurement: Instruments and approaches. Archives of Physical Medicine and Rehabilitation, 84(4, Suppl. 2), S3-S14. (Pubitemid 36417637)
11. Fairclough, D.L. (1997). Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy. Statistics in Medicine, 16, 1197-1209. (Pubitemid 27252592)
12. Fairclough, D.L. (2004). Patient reported outcomes as endpoints in medical research. Statistical Methods in Medical Research, 13, 115-138. (Pubitemid 38379776)
13. Ferrans, C.E. (1990a). Development of a quality of life index for patients with cancer. Oncology Nursing Forum, 17(3, Suppl.), 15-19.
14. Ferrans, C.E. (1990b). Quality of life: Conceptual issues. Seminars in Oncology Nursing, 6, 248-254.
15. Ferrans, C.E., & Powers, M.J. (1985). Quality of life index: Development and psychometric properties. Advances in Nursing Science, 8(1), 15-24.
16. Fong, D., Lam, K.F., Kwan, C.W., Sham, J.S., & Karlberg, J.P. (2004). False positive error in the analysis of paired quality of life data [Abstract 1330]. Quality of Life Research, 13, 1521.
17. Frost, M.H., Bonomi, A.E., Ferrans, C., Wong, G.Y., Hays, R.D., & Clinical Significance Consensus Meeting Group. (2002). Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clinic Proceedings, 77, 488-494. (Pubitemid 34465157)
18. Guyatt, G.H., Osoba, D., Wu, A.W., Wyrwich, K.W., Norman, G.R., & Clinical Significance Consensus Meeting Group. (2002). Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings, 77, 371-383. (Pubitemid 34260746)
19. Haberman, M.R., & Bush, N. (2003). Quality of life methodological and measurement issues. In C.R. King & P.S. Hinds (Eds.), Quality of life from nursing and patient perspectives: Theory, research, practice (2nd ed., pp. 171-198). Sudbury, MA: Jones and Bartlett.
20. Hays, R.D., Anderson, R.T., & Revicki, D. (1998). Assessing reliability and validity of measurement in clinical trials. In M.J. Staquet, R.D. Hays, & P.M. Fayers (Eds.), Quality of life assessment in clinical trials: Methods and practice (pp. 169-182). Oxford, England: Oxford University Press.
21. Hays, R.D., & Woolley, J.M. (2000). The concept of clinically meaningful difference in health-related quality-of-life research: How meaningful is it? Pharmacoeconomics, 18, 419-423.
22. Hymovich, D.P. (2004). Measurement issues with children and adolescents. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 33-46). Sudbury, MA: Jones and Bartlett.
23. Jaeschke, R., Singer, J., & Guyatt, G.H. (1989). Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10, 407-415. (Pubitemid 20025670)
24. Kazdin, A.E. (1999). The meanings and measurement of clinical significance. Journal of Consulting Clinical Psychology, 67, 332-339. (Pubitemid 29266502)
25. Kendall, P.C., Marrs-Garcia, A., Nath, S.R., & Sheldrick, R.C. (1999). Normative comparisons for the evaluation of clinical significance. Journal of Consulting and Clinical Psychology, 67, 285-299. (Pubitemid 29266498)
26. King, C.R., Haberman, M., Berry, D.L., Bush, N., Butler, L., Dow, K.H., et al. (1997). Quality of life and the cancer experience: The state-of-the-knowledge. Oncology Nursing Forum, 24, 27-41.
27. King, C.R., & Hinds, P.S. (Eds.). (2003). Quality of life from nursing and patient perspectives: Theory, research, practice (2nd ed.). Sudbury, MA: Jones and Bartlett.
28. Marin, G., & Marin, B.V. (1991). Research with Hispanic populations. Newbury Park, CA: Sage.
29. Mayo Clinic. (2002). Symposium on the clinical significance of quality of life measures in cancer patients. Mayo Clinic Proceedings, 77(Suppl.), 367-563.
30. McHorney, C.A., & Tarlov, A.R. (1995). Individual-patient monitoring in clinical practice: Are available health status surveys adequate? Quality of Life Research, 4, 293-307.
31. McMillan, S.C., & Small, B.J. (2002). Symptom distress and quality of life in patients with cancer newly admitted to hospice home care. Oncology Nursing Forum, 29, 1421-1428.
32. McMillan, S.C., & Weitzner, M. (1998). Quality of life in cancer patients: Use of a revised Hospice Index. Cancer Practice, 6, 282-288. (Pubitemid 28423945)
33. Moinpour, C.M., Sawyers Triplett, J., McKnight, B., Lovato, L.C., Upchurch, C., Leichman, C.G., et al. (2000). Challenges posted by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial. Psycho-Oncology, 9, 340-354.
34. Montero, D. (1977). Research among racial and cultural minorities: An overview. Journal of Social Issues, 33(4), 1-10.
35. Omery, A.K., & Dean, H. (2004). Multiple instruments for measuring quality of life. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 150-161). Sudbury, MA: Jones and Bartlett.
36. Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16, 139-144. (Pubitemid 28041591)
37. Padilla, G.V., Frank-Stromborg, M., & Koresawa, S. (2004). Single instruments for measuring quality of life. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 128-163). Sudbury, MA: Jones and Bartlett.
38. Patrick, D.L., & Chiang, Y.P. (2000). Measurement of health outcomes in treatment effectiveness evaluations: Conceptual and methodological challenges. Medical Care, 38(9, Suppl.), II14-II25.
39. Rasin, J.H. (2004). Measurement issues with the elderly. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 47-55). Sudbury, MA: Jones and Bartlett.
40. Redelmeier, D.A., & Tversky, A. (1990). Discrepancy between medical decisions for individual patients and for groups. New England Journal of Medicine, 322, 1162-1164. (Pubitemid 20149556)
41. Ropka, M.E., Guterbock, T., Krebs, L., Murphy-Ende, K., Stetz, K., Summers, B., et al. (2002). Year 2000 Oncology Nursing Society research priorities survey. Oncology Nursing Forum, 29, 481-491.
42. Rubenstein, L.V. (1996). Using quality of life tests for the patient diagnosis or screening or to evaluate treatment. In B. Spilker (Ed.), Quality of life and pharmacoeconomics in clinical trials (2nd ed., pp. 363-374). Philadelphia: Lippincott-Raven.
43. Samsa, G., Edelman, D., Rothman, M.L., Williams, G.R., Lipscomb, J., & Matchar, D. (1999). Determining clinically important differences in health status measures: A general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics, 15, 141-155. (Pubitemid 29093257)
44. Sloan, J.A., Aaronson, N., Cappelleri, J.C., Fairclough, D.L., Varricchio, C.G., & Clinical Significance Consensus Meeting Group. (2002). Assessing the clinical significance of single items relative to summated scores. Mayo Clinic Proceedings, 77, 479-487. (Pubitemid 34465156)
45. Sloan, J.A., Cella, D., Frost, M., Guyatt, G.H., Sprangers, M., Symonds, T., et al. (2002). Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms. Mayo Clinic Proceedings, 77, 367-370. (Pubitemid 34260745)
46. Sloan, J.A., Loprinzi, C.L., Kuross, S.A., Miser, A.W., O'Fallon, J.R., Mahoney, M.R., et al. (1998). Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. Journal of Clinical Oncology, 16, 3662-3673. (Pubitemid 28506782)
47. Sloan, J.A., & Varricchio, C. (2001). Quality of life endpoints in prostate chemoprevention trials. Urology, 57(4, Suppl. 1), 235-240. (Pubitemid 33733956)
48. Spitzer, W.O., Dobson, A.J., Hall, J., Chesterman, E., Levi, J., Shepherd, R., et al. (1981). Measuring the quality of life of cancer patients: A concise QL index for use by physicians. Journal of Chronic Diseases, 34, 585-597. (Pubitemid 12237535)
49. Sprangers, M.A., Moinpour, C.M., Moynihan, T.J., Patrick, D.L., Revicki, D.A., & Clinical Significance Consensus Meeting Group. (2002). Assessing meaningful changes in quality of life over time: A users' guide for clinicians. Mayo Clinic Proceedings, 77, 561-571. (Pubitemid 34587346)
50. Sprangers, M.A., & Schwartz, C.E. (1999). The challenge of response shift for quality-of-life-based clinical oncology research. Annals of Oncology, 10, 747-749. (Pubitemid 29367988)
51. Sprangers, M.A., van Dam, F.S., Broersen, J., Lodder, L., Wever, L., Visser, M.R., et al. (1999). Revealing response shift in longitudinal research on fatigue-The use of the thentest approach. Acta Oncologica, 38, 709-718. (Pubitemid 29441433)
52. Symonds, T., Berzon, R., Marquis, P., Rummans, T.A., & Clinical Significance Consensus Meeting Group. (2002). The clinical significance of quality of life results: Practical considerations for specific audiences. Mayo Clinic Proceedings, 77, 572-583. (Pubitemid 34587347)
53. Vallerand, A.H., & Payne, J.K. (2003). Theories and conceptual models to guide quality of life related research. In C.R. King & P.S. Hinds (Eds.), Quality of life from nursing and patient perspectives: Theory, research, practice (2nd ed., pp. 45-64). Sudbury, MA: Jones and Bartlett.
54. Varricchio, C.G. (2004). Measurement issues concerning linguistic translations. In M. Frank-Stromborg & S.J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 56-64). Sudbury, MA: Jones and Bartlett.
55. Ware, J.E., Jr. (2003). Conceptualization and measurement of health-related quality of life: Comments on an evolving field. Archives of Physical Medicine and Rehabilitation, 84(4, Suppl. 2), S43-S51. (Pubitemid 36417642)
56. Ware, J.E., Jr., Kosinski, M., & Keller, S.D. (1994). SF 36physical and mental health summary scales: A user's manual. Boston: New England Medical Center.
57. Warnecke, R.B., Ferrans, C.E., Johnson, T.P., Chapa-Resendez, G., O'Rourke, D.P., Chavez, N., et al. (1996). Measuring quality of life in culturally diverse populations. Journal of the National Cancer Institute Monographs, 20, 29-38.
58. Westerman, M.J., & Hak, T. (2004). Response shift in quality of life in patients with small cell lung cancer [Abstract 1196]. Quality of Life Research, 13, 1521.
59. World Health Organization. (1993). WHO QOL study protocol: The development of the World Health Organization quality of life assessment instrument (Publication No. MNH/PSF/93.9). Geneva, Switzerland: Author.
60. Wyrwich, K.W., Bullinger, M., Aaronson, N., Hays, R.D., Patrick, D.L., Symonds, T., et al. (2005). Estimating clinically significant differences in quality of life outcomes. Quality of Life Research, 14, 185-295.